스카이메디

All filings by 스카이메디 on record concern 메디포스트. Over a trading history stretching from 15 April 2022 to 6 January 2026, the count stands at 39 filings.

The open-market side counts 1 purchase alongside 38 sales. No amount is published for 39 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.

Most recently, on 13 January 2026, the filings show an open-market purchase in 메디포스트. Filings reach the DART (FSS) feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.